Venturi Wealth Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-975
Closed -$88.5K 617
2024
Q4
$88.5K Buy
975
+779
+397% +$71.5K ﹤0.01% 829
2024
Q3
$18.9K Buy
196
+48
+32% +$4.68K ﹤0.01% 1029
2024
Q2
$13.6K Buy
148
+98
+196% +$9.09K ﹤0.01% 1036
2024
Q1
$4.61K Sell
50
-13
-21% -$1.22K ﹤0.01% 1111
2023
Q4
$5.99K Buy
63
+10
+19% +$934 ﹤0.01% 994
2023
Q3
$4.95K Sell
53
-48
-48% -$4.43K ﹤0.01% 984
2023
Q2
$9.24K Hold
101
﹤0.01% 664
2023
Q1
$7.43K Buy
+101
New +$8.74K ﹤0.01% 761
2021
Q2
Sell
-959
Closed -$254K 312
2021
Q1
$254K Buy
959
+220
+30% +$62K 0.02% 276
2020
Q4
$217K Sell
739
-197
-21% -$50.5K 0.02% 281
2020
Q3
$221K Buy
+936
New +$213K 0.03% 261

Other funds holding AMED

Venturi Wealth Management's AMED Position: Q1 2025 in Review

Venturi Wealth Management sold out of Amedisys (AMED) in Q1 2025, closing a stake of 975 shares — an estimated $88.5K sold.

Venturi Wealth Management first reported a position in AMED in Q3 2020 and held it in 11 quarters. The position peaked at $254K in Q1 2021. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Venturi Wealth Management reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 975 Amedisys shares in Q1 2025, an estimated $88.5K.
  • Venturi Wealth Management first reported a position in Amedisys in Q3 2020 and held it in 11 quarters.
  • Venturi Wealth Management's Amedisys position peaked at $254K in Q1 2021.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.